Han, J., McCall, C. M., Isom, S., Smith, W. M., Begley, S., Jenneman, D., … Ghosh, N. (2025). High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy. Leuk Lymphoma, 66(2), 325–328. https://doi.org/10.1080/10428194.2024.2414899

Han, Jianmin, Chad M. McCall, Scott Isom, Wesley Matthew Smith, Stephanie Begley, Dakota Jenneman, Rupali Bose, Mary Beth Seegars, Eric D. Hsi, and Nilanjan Ghosh. “High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy.” Leuk Lymphoma 66, no. 2 (February 2025): 325–28. https://doi.org/10.1080/10428194.2024.2414899.

Han J, McCall CM, Isom S, Smith WM, Begley S, Jenneman D, et al. High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy. Leuk Lymphoma. 2025 Feb;66(2):325–8.

Han, Jianmin, et al. “High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy.” Leuk Lymphoma, vol. 66, no. 2, Feb. 2025, pp. 325–28. Pubmed, doi:10.1080/10428194.2024.2414899.

Han J, McCall CM, Isom S, Smith WM, Begley S, Jenneman D, Bose R, Seegars MB, Hsi ED, Ghosh N. High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy. Leuk Lymphoma. 2025 Feb;66(2):325–328.